Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F

Innate Pharma SA announced the filing of its 2023 Universal Registration Document for the year ending December 31, 2023 with the French market authority “Autorité des Marchés Financiers” on April 4, 2024.